Gene · 2798
Papers2,995
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,995
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Folding, misfolding, and regulation of intracellular traffic of G protein-coupled receptors involved in the hypothalamic-pituitary-gonadal axis. | Andrology | 2026 | 40052453 | PubTator, text mining | PubMed |
| Cetrorelix promotes cell apoptosis via the PI3K-AKT-FOXO1 pathway in epithelial ovarian cancer. | Front Oncol | 2025 | 41458598 | PubTator, text mining | PubMed |
| Clinical approach to the male with delayed puberty. | Arch Endocrinol Metab | 2025 | 41312956 | PubTator, text mining | PubMed |
| Computational modelling reveals novel insights into GnRH receptor activation and binding dynamics. | Sci Rep | 2025 | 41310347 | PubTator, text mining | PubMed |
| Radiolabeled LHRH and FSH Analogues as Cancer Theranostic Agents: A Systematic Review. | J Clin Med | 2025 | 41227206 | PubTator, text mining | PubMed |
| A familial case of Kallmann syndrome: novel variants in ANOS1 and GNRHR genes. | Arch Endocrinol Metab | 2025 | 41165467 | PubTator, text mining | PubMed |
| Differential hypothalamic regulation of FSH and LH secretion from the fish pituitary by GnRH and CCK. | Reproduction | 2025 | 41151532 | PubTator, text mining | PubMed |
| Dual-route embedding-aware graph neural networks for drug repositioning. | Brief Bioinform | 2025 | 41139923 | PubTator, text mining | PubMed |
| N-carbamylglutamate supplementation improves laying performance of layers by regulating hypothalamic-pituitary-ovarian axis. | Front Vet Sci | 2025 | 41112153 | PubTator, text mining | PubMed |
| Mechanism of GPR173-Mediated Suppression of TNBC Proliferation and Metastatic Potential via GnRHR Upregulation. | Clin Med Insights Oncol | 2025 | 41031152 | PubTator, text mining | PubMed |
| Clinical efficacy and influence on the quality of life of children with precocious puberty treated by combination of cluster nursing and triptorelin. | Medicine (Baltimore) | 2025 | 40988204 | PubTator, text mining | PubMed |
| Aberrant Expression of Gonadotropin-Releasing Hormone Receptor in Human Mast Cells Enhances the Recruitments of Trophoblasts and NK Cells. | Am J Reprod Immunol | 2025 | 40966309 | PubTator, text mining | PubMed |
| Triptorelin associated adverse events evaluated using FAERS pharmacovigilance data. | Sci Rep | 2025 | 40890214 | PubTator, text mining | PubMed |
| Elevated serum phoenixin levels in boys with central precocious puberty are positively correlated with BMI. | Endocr Connect | 2025 | 40823903 | PubTator, text mining | PubMed |
| PIT-1/SF-1-positive pituitary tumors in patients with acromegaly: transcriptomic perspective. | Acta Neuropathol Commun | 2025 | 40813692 | PubTator, text mining | PubMed |
Apalutamide Monotherapy in Metastatic Hormone-Sensitive Prostate Cancer: A Viable Alternative to First-Generation Anti-Androgen Agents to Avoid the Flare Phenomenon and an Effective Treatment for Achieving Early PSA Response. | Cancers (Basel) | 2025 | 40805269 | PubTator, text mining | PubMed |
| Pathway polygenic risk scores (pPRS) for the analysis of gene-environment interaction. | PLoS Genet | 2025 | 40763299 | PubTator, text mining | PubMed |
| Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Endometriosis: Advances in Research. | J Clin Med Res | 2025 | 40641861 | PubTator, text mining | PubMed |
| Phytoestrogen Signal Pathways and Estrogen Signaling in Ovarian Cancer: A Narrative Review. | Phytother Res | 2025 | 40634118 | PubTator, text mining | PubMed |
| Red meat intake interacts with a TGF-β-pathway-based polygenic risk score to impact colorectal cancer risk: Application of a novel approach for polygenic risk score construction. | medRxiv | 2025 | 40568668 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2798/papers?page=3